Market Place
Sourcing Support
Novartis, Ratio sign radiopharmaceutical pact of $745M
19 Nov 2024 //
FIERCE BIOTECH
Ratio Therapeutics Appoints Ex-Senator William Cowan To Board Of Directors
20 Jun 2024 //
PR NEWSWIRE
Ratio Therapeutics Appoints Marc Becker As CFO, COO
06 May 2024 //
PR NEWSWIRE
Ratio Therapeutics Appoints Bill as CBO & Holbrook to its Board of Directors
02 Apr 2024 //
PR NEWSWIRE
Ratio Therapeutics Announces $50M Series B Financing
17 Jan 2024 //
PR NEWSWIRE
Ratio raises $50M as radiopharma field finds its groove
17 Jan 2024 //
ENDPTS
Ratio Therapeutics Announces Opening of New Research and Development Facility
09 May 2023 //
PR NEWSWIRE
Ratio Announces Agreement for Investigational PET Imaging Agent with Merck
28 Mar 2023 //
PR NEWSWIRE
Ratio Therapeutics Appoints Dr. Noel Monks as Head of Biology
13 Mar 2023 //
PR NEWSWIRE
Ratio Therapeutics Announces $20M Series A Financing
01 Feb 2023 //
PR NEWSWIRE
Ratio Therapeutics Appoints Jacob Hesterman, Ph.D., as Chief Data Officer
15 Sep 2022 //
PRNEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.